HIV and Its Coreceptors Outline

HIV is a human immune system * To understand HIV, it is necessary to understand the human immune system. The first line of defense is the human skin, mucosa, and other secretions that prevent pathogens from entering your body. Pathogens are thought to be something your body does not need like bacteria and viruses. The second line of defense includes nonspecific mechanisms to suppress the spread of pathogens throughout the body. The second line of defense is heavily dependent on the use of white blood cells. And it ingests invading creatures.

HIV usually uses CD4 and co-receptors to infect cells. The most common HIV co-receptors are the chemokine receptors CCR5 and CXCR4. Most primary infections include viruses that use CCR5 as a co-receptor, but CXCR4 using viruses is associated with faster disease progression, confirmed by those with more advanced disease. Please enter the target cell. HIV interacts with the CD4 receptor via its gp 120 protein, thereby stimulating the conformational change of gp 120, which exposes a part of the transmembrane glycoprotein gp41 and that the gp 120 V loop enters CCR 5 or CXCR 4 . Subsequently, the peptide in gp41 causes fusion of the viral envelope and the host cell membrane and allows the viral capsid to enter the target cell.

HIV infection begins when the envelope glycoprotein (Env) of the virus particle binds to a co-receptor that is a member of CD4 and the chemokine receptor family (Abbas et al., 2003). Co-receptor binding induces a conformational change in gp41 that exposes hydrophobic regions called fusion peptides that are inserted into the cell membrane to promote viral membrane fusion. Free HIV particles released from infected cells can bind to uninfected cells (Abbas et al, 2003). Envelope glycoprotein gp160 and its cleavage products, transmembrane protein gp41 and surface protein gp120 have been the major antigens for vaccine production so far (Merigan et al., 1999).

Essay.com / explains the immune response to human immunodeficiency virus (HIV) and explains the latest developments in the development of safe HIV defense vaccines

Explain the immune response to human immunodeficiency virus (HIV) and discuss the latest developments in the development of safe HIV defense vaccines